<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>In vivo</italic>, zidovudine can reduce plasma viral load, improve the immunologic and clinical status of FIV-infected cats, increase quality of life, and prolong life expectancy [
 <xref rid="B16-vetsci-02-00456" ref-type="bibr">16</xref>]. In placebo-controlled trials, zidovudine improved stomatitis and increased the CD4/CD8 ratio in naturally FIV-infected cats. In some cats with FIV-associated neurologic signs, marked improvement was reported within the first days of therapy [
 <xref rid="B28-vetsci-02-00456" ref-type="bibr">28</xref>,
 <xref rid="B29-vetsci-02-00456" ref-type="bibr">29</xref>].
</p>
